Koramit Suppipat, M.D., Director of Cellular Immunotherapy Research Unit Faculty of Medicine Chulalongkorn University said that the CAR T-cell treatment is an immunotherapy that uses genetically modified T cells to target and destroy cancer cells that do not respond to standard treatments. The cell production and quality control lab in the new integrated research building has been expanded and combined with the hospital ward that focuses on complete care for cancer patients to form “King Chulalongkorn Memorial Hospital’s Integrated Cancer Research and Treatment Center” to sufficiently serve patients in the future.” At the same time, the Faculty of Medicine has been continuously building the infrastructure to most quickly implement the research inpatient treatment. This collaborative research with Nagoya University in Japan has helped advance the research tremendously. However, there are numerous limitations to the widespread application of this method, including high costs, complicated procedures, and further research needed for practicality in more cancer patients. The CAR T-cell immunotherapy innovation, in particular, is a new treatment for leukemia and lymphoma, which can increase survival rates and decrease cancer recurrence. Chanchai Sittipunt, M.D., Dean of the Faculty of Medicine, Chulalongkorn University, and Director of King Chulalongkorn Memorial Hospital, said that “the Cancer Immunotherapy Excellence Center is one of Chulalongkorn University’s Faculty of Medicine’s specialized projects. This research project is a collaboration between the Cancer Immunotherapy Excellence Center, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thailand, and Tokai National Higher Education and Research System and School of Medicine, Nagoya University, Japan.Īssoc. The talk presented the progress of CAR T-cell immunotherapy innovation for treating cancer in leukemia and B-cell lymphoma patients. Chulalongkorn University and the Faculty of Medicine, Chulalongkorn University, organized the 17 th Chula the Impact on “CAR T-Cell Cancer Therapy Innovation: New Hope for Thai Cancer Patients” on Tuesday, March 28, 2023, at Saranitet Conference Room, Chulalongkorn Auditorium.
0 kommentar(er)
